First-line treatment with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetic population at low risk of cardiovascular disease: a meta-analysis

BackgroundThe benefit of first-line use of sodium-dependent glucose transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 2 diabetes mellitus (T2DM) with low risk of cardiovascular diseases are not clear.MethodsPubMed, EMBASE and Cochrane Library databases...

全面介绍

书目详细资料

Principais autores:	Rui Deng, Kaibo Mei, Tiangang Song, Jinyi Huang, Yifan Wu, Peng Yu, Zhiwei Yan, Xiao Liu
格式:	Artigo
语言:	Inglês
出版:	Frontiers Media S.A. 2024-01-01
丛编:	Frontiers in Endocrinology
主题:	sodium-glucose cotransporter 2 inhibitors glucagon-like peptide-1 receptor agonists type 2 diabetes metformin meta-analysis
在线阅读:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1289643/full
标签:	添加标签 没有标签, 成为第一个标记此记录!